4147.TWO
Price:
$62.8
Market Cap:
$17.16B
TaiMed Biologics Inc., a biotechnology company, develops, manufactures, and commercializes various drugs for the treatment and prevention of infectious diseases. The company develops and markets Ibalizumab (TMB-355) Intravenous Infusion, a humanized monoclonal antibody for the treatment of HIV-1 infection. It is also developing TMB-355 Intravenous Push, a humanized monoclonal antibody for the treatment of HIV-1 infection; TMB-355 Intramuscular Injection, a humanized monoclonal antibody intramuscular injection, which is in Phase III clinical trials for treating HIV-1; TMB-365, an anti-CD4 recombinant humanized monoclonal antibody, which completed Phase I clinical trials for treating HIV infec...[Read more]
Industry
Biotechnology
IPO Date
2012-06-20
Stock Exchange
TWO
Ticker
4147.TWO
According to TaiMed Biologics Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -79.49. This represents a change of -58.95% compared to the average of -193.63 of the last 4 quarters.
The mean historical PE Ratio of TaiMed Biologics Inc. over the last ten years is -96.97. The current -79.49 PE Ratio has changed 8.10% with respect to the historical average. Over the past ten years (40 quarters), 4147.TWO's PE Ratio was at its highest in in the March 2021 quarter at 996.85. The PE Ratio was at its lowest in in the September 2023 quarter at -969.27.
Average
-96.97
Median
-110.33
Minimum
-148.79
Maximum
-37.77
Discovering the peaks and valleys of TaiMed Biologics Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 162.40%
Maximum Annual PE Ratio = -37.77
Minimum Annual Increase = -67.11%
Minimum Annual PE Ratio = -148.79
| Year | PE Ratio | Change |
|---|---|---|
| 2024 | -114.28 | 7.43% |
| 2023 | -106.38 | 64.18% |
| 2022 | -64.79 | 71.53% |
| 2021 | -37.77 | -67.11% |
| 2020 | -114.83 | 162.40% |
| 2019 | -43.76 | -66.15% |
| 2018 | -129.28 | 42.48% |
| 2017 | -90.74 | -39.02% |
| 2016 | -148.79 | 25.00% |
| 2015 | -119.03 | -4.55% |
The current PE Ratio of TaiMed Biologics Inc. (4147.TWO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-95.15
5-year avg
-87.61
10-year avg
-96.97
TaiMed Biologics Inc.’s PE Ratio is less than EirGenix Inc. (-27.20), less than Pell Bio-Med Technology Co., Ltd. (-56.91), less than Sunmax Biotechnology Co., Ltd. (29.65), less than Medigen Vaccine Biologics Corporation (-73.18), less than Tanvex BioPharma, Inc. (-11.30), less than Lin BioScience, Inc. (-46.66), less than Handa Pharmaceuticals, Inc. (21.97), greater than Caliway Biopharmaceuticals Co., Ltd. (-506.29), less than TTY Biopharm Company Limited (13.25), less than Ever Supreme Bio Technology Co., Ltd (27.60),
| Company | PE Ratio | Market cap |
|---|---|---|
| -27.20 | $19.22B | |
| -56.91 | $21.09B | |
| 29.65 | $21.24B | |
| -73.18 | $12.34B | |
| -11.30 | $16.05B | |
| -46.66 | $33.67B | |
| 21.97 | $15.56B | |
| -506.29 | $24.55B | |
| 13.25 | $20.89B | |
| 27.60 | $14.37B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like TaiMed Biologics Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like TaiMed Biologics Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is TaiMed Biologics Inc.'s PE Ratio?
How is the PE Ratio calculated for TaiMed Biologics Inc. (4147.TWO)?
What is the highest PE Ratio for TaiMed Biologics Inc. (4147.TWO)?
What is the 3-year average PE Ratio for TaiMed Biologics Inc. (4147.TWO)?
What is the 5-year average PE Ratio for TaiMed Biologics Inc. (4147.TWO)?
How does the current PE Ratio for TaiMed Biologics Inc. (4147.TWO) compare to its historical average?